Posts by: Marisa Wexler MS

Marisa Wexler MS

Marisa, a science writer, holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

January 12, 2021January 12, 2021

Phase 1/2 Trial to Test Phage Therapy for Chronic P. aeruginosa Infections

cystic fibrosis, News

A Phase 1/2 clinical trial, called CYPHY, to evaluate the phage therapy YPT-01 in treating chronic Pseudomonas aeruginosa infections in people with cystic fibrosis (CF) has been initiated at ... Read more

January 8, 2021January 8, 2021

Study Examines Effects of Socioeconomics on Health of Youngsters

cystic fibrosis, News

Children with cystic fibrosis (CF) who live in more socioeconomically disadvantaged areas of the U.S. tend to have worse lung function and health outcomes than their counterparts in more ... Read more

January 5, 2021January 5, 2021

Health Canada Giving Priority Review to Trikafta

cystic fibrosis, News

Health Canada is reviewing an application that seeks the approval of Trikafta, a triple combination reported to treat 90% of all with cystic fibrosis (CF), or those with least one F508del ... Read more

December 16, 2020December 16, 2020

Potential Antibiotic Appears to Effectively Treat M. abscessus Infections

cystic fibrosis, News

A newly developed antibiotic, called T405, appears to effectively kill Mycobacteroides abscessus, a difficult-to-treat bacteria that can cause serious infections in people with lung conditions like cystic fibrosis (CF). ... Read more

December 10, 2020December 10, 2020

CF Children With COVID-19 Usually Do Not Develop Serious Disease, Study Finds

cystic fibrosis, News

Children with cystic fibrosis (CF) who become infected with SARS-CoV-2 — the virus that causes COVID-19 — usually have a mild disease course, a new study reports. The findings also ... Read more

December 7, 2020December 7, 2020

Study Identifies Risk Factors of Malnutrition in Children With CF

News

Children with cystic fibrosis (CF) who are older, thinner, or have worse lung function may be at increased risk of malnutrition, a study indicates. These findings highlight the importance ... Read more

December 3, 2020December 3, 2020

BiomX Testing Potential Therapy for CF Lung Infections

cystic fibrosis, News

BiomX has unveiled a platform designed for more rapid and efficient development of phage therapy, which the company is using to test potential treatments, including one for Pseudomonas aeruginosa infections ... Read more

December 2, 2020December 2, 2020

Trial Testing MS1819 Plus PERT for Exocrine Pancreatic Insufficiency Now Dosing in Turkey

cystic fibrosis, News

A clinical trial testing AzurRx BioPharma‘s investigational therapy MS1819, in combination with the current standard care for the treatment of severe exocrine pancreatic insufficiency (EPI) in patients with cystic ... Read more

November 25, 2020November 25, 2020

CFF Awards $3.3M to Advance Inhaled Antibiotic for Resistant P. aeruginosa Infections

cystic fibrosis, News

The Cystic Fibrosis Foundation (CFF) has awarded up to $3.3 million to Polyphor AG to advance the testing of an inhaled version of murepavadin, an antibiotic that targets multi-drug ... Read more

November 19, 2020November 19, 2020

Trial of MS1819, Pancreatic Enzyme Therapy, May Add New Patient Arm

cystic fibrosis, News

AzurRx BioPharma is requesting a new patient arm be added to its ongoing Phase 2b trial investigating MS1819 capsules as a treatment for exocrine pancreatic insufficiency (EPI) in people with cystic fibrosis (CF). ... Read more